rs76599133

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_138477.4(CDAN1):​c.816C>A​(p.Thr272Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0175 in 1,614,048 control chromosomes in the GnomAD database, including 1,784 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.060 ( 776 hom., cov: 32)
Exomes 𝑓: 0.013 ( 1008 hom. )

Consequence

CDAN1
NM_138477.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.228

Publications

6 publications found
Variant links:
Genes affected
CDAN1 (HGNC:1713): (codanin 1) This gene encodes a protein that appears to play a role in nuclear envelope integrity, possibly related to microtubule attachments. Mutations in this gene cause congenital dyserythropoietic anemia type I, a disease resulting in morphological and functional abnormalities of erythropoiesis. [provided by RefSeq, Jul 2009]
CDAN1 Gene-Disease associations (from GenCC):
  • anemia, congenital dyserythropoietic, type 1a
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital dyserythropoietic anemia type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital dyserythropoietic anemia
    Inheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 15-42735637-G-T is Benign according to our data. Variant chr15-42735637-G-T is described in ClinVar as Benign. ClinVar VariationId is 262380.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.228 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDAN1NM_138477.4 linkc.816C>A p.Thr272Thr synonymous_variant Exon 4 of 28 ENST00000356231.4 NP_612486.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDAN1ENST00000356231.4 linkc.816C>A p.Thr272Thr synonymous_variant Exon 4 of 28 1 NM_138477.4 ENSP00000348564.3
CDAN1ENST00000643434.1 linkn.*115C>A non_coding_transcript_exon_variant Exon 3 of 25 ENSP00000494699.1
CDAN1ENST00000643434.1 linkn.*115C>A 3_prime_UTR_variant Exon 3 of 25 ENSP00000494699.1

Frequencies

GnomAD3 genomes
AF:
0.0601
AC:
9137
AN:
152092
Hom.:
769
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.184
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0253
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.0365
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00315
Gnomad OTH
AF:
0.0465
GnomAD2 exomes
AF:
0.0299
AC:
7491
AN:
250348
AF XY:
0.0271
show subpopulations
Gnomad AFR exome
AF:
0.189
Gnomad AMR exome
AF:
0.0145
Gnomad ASJ exome
AF:
0.00578
Gnomad EAS exome
AF:
0.128
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00343
Gnomad OTH exome
AF:
0.0157
GnomAD4 exome
AF:
0.0131
AC:
19091
AN:
1461840
Hom.:
1008
Cov.:
32
AF XY:
0.0131
AC XY:
9529
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.191
AC:
6402
AN:
33480
American (AMR)
AF:
0.0165
AC:
738
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00520
AC:
136
AN:
26136
East Asian (EAS)
AF:
0.104
AC:
4130
AN:
39700
South Asian (SAS)
AF:
0.0345
AC:
2973
AN:
86258
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53388
Middle Eastern (MID)
AF:
0.0231
AC:
133
AN:
5766
European-Non Finnish (NFE)
AF:
0.00270
AC:
3003
AN:
1111992
Other (OTH)
AF:
0.0258
AC:
1560
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1202
2403
3605
4806
6008
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0603
AC:
9172
AN:
152208
Hom.:
776
Cov.:
32
AF XY:
0.0588
AC XY:
4375
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.184
AC:
7637
AN:
41484
American (AMR)
AF:
0.0253
AC:
387
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00518
AC:
18
AN:
3472
East Asian (EAS)
AF:
0.122
AC:
629
AN:
5176
South Asian (SAS)
AF:
0.0365
AC:
176
AN:
4824
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10624
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00315
AC:
214
AN:
68016
Other (OTH)
AF:
0.0456
AC:
96
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
391
782
1172
1563
1954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0322
Hom.:
187
Bravo
AF:
0.0670
Asia WGS
AF:
0.0810
AC:
282
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00409

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital dyserythropoietic anemia, type I Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Anemia, congenital dyserythropoietic, type 1a Benign:1
Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
6.0
DANN
Benign
0.64
PhyloP100
0.23
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76599133; hg19: chr15-43027835; COSMIC: COSV51177738; COSMIC: COSV51177738; API